| Literature DB >> 27072748 |
Asaf Spiegel1, Mary W Brooks1, Samin Houshyar1, Ferenc Reinhardt1, Michele Ardolino2, Evelyn Fessler1, Michelle B Chen3, Jordan A Krall1, Jasmine DeCock1, Ioannis K Zervantonakis3, Alexandre Iannello2, Yoshiko Iwamoto4, Virna Cortez-Retamozo4, Roger D Kamm3, Mikael J Pittet4, David H Raulet2, Robert A Weinberg5.
Abstract
UNLABELLED: Immune cells promote the initial metastatic dissemination of carcinoma cells from primary tumors. In contrast to their well-studied functions in the initial stages of metastasis, the specific roles of immunocytes in facilitating progression through the critical later steps of the invasion-metastasis cascade remain poorly understood. Here, we define novel functions of neutrophils in promoting intraluminal survival and extravasation at sites of metastatic dissemination. We show that CD11b(+)/Ly6G(+) neutrophils enhance metastasis formation via two distinct mechanisms. First, neutrophils inhibit natural killer cell function, which leads to a significant increase in the intraluminal survival time of tumor cells. Thereafter, neutrophils operate to facilitate extravasation of tumor cells through the secretion of IL1β and matrix metalloproteinases. These results identify neutrophils as key regulators of intraluminal survival and extravasation through their cross-talk with host cells and disseminating carcinoma cells. SIGNIFICANCE: This study provides important insights into the systemic contributions of neutrophils to cancer metastasis by identifying how neutrophils facilitate intermediate steps of the invasion-metastasis cascade. We demonstrate that neutrophils suppress natural killer cell activity and increase extravasation of tumor cells. Cancer Discov; 6(6); 630-49. ©2016 AACR.This article is highlighted in the In This Issue feature, p. 561. ©2016 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27072748 PMCID: PMC4918202 DOI: 10.1158/2159-8290.CD-15-1157
Source DB: PubMed Journal: Cancer Discov ISSN: 2159-8274 Impact factor: 39.397